Igor Smolenov

mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials

Robert Feldman, Rainard Fuhr, Igor Smolenov et al. · Vaccine · 2019 · 453 citations · Full text

Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial

Peter Richmond, Lara Hatchuel, Min Dong et al. · The Lancet · 2021 · 279 citations · Full text

A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults

Antonios O. Aliprantis, Christine A. Shaw, Paul Griffin et al. · Human Vaccines & Immunotherapeutics · 2020 · 145 citations · Full text

Respiratory Virus Immunity, Viral Immunity, Immunology +19

Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study

Kong Boo Phua, Filip Lim, YL Lau et al. · Vaccine · 2009 · 142 citations

Vaccination, Vaccine Safety, Maternal Immunization +8

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

Lulu Bravo, Igor Smolenov, Htay Htay Han et al. · The Lancet · 2022 · 112 citations · Full text

Vaccinology, Vaccine Safety, Vaccination +9